Clinical significance of donor-specific anti-HLA-DR51/52/53 antibodies for antibody-mediated rejection in kidney transplant recipients

BACKGROUND: The presence of donor-specific antibodies (DSAs) to human leukocyte antigen (HLA) increases the risk of antibody-mediated rejection (ABMR) after kidney transplantation (KT). However, the clinical relevance of anti-HLA-DR51/52/53 antibodies remains unclear because of their weak antigen ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Borae Geum, Park, Younhee, Joo, Dong Jin, Huh, Kyu Ha, Kim, Myoung Soo, Kim, Soon Il, Kim, Yu Seun, Kim, Hyon-Suk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Transplantation 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188942/
https://www.ncbi.nlm.nih.gov/pubmed/35769408
http://dx.doi.org/10.4285/jkstn.2019.33.3.47

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188942/
https://www.ncbi.nlm.nih.gov/pubmed/35769408
http://dx.doi.org/10.4285/jkstn.2019.33.3.47

Ejemplares similares